Karuna Therapeutics's market cap is currently ―. The company's EPS TTM is $-11.726; its P/E ratio is -28.13; Karuna Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-2.73. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	$ 147.00K	$ 147.00K	$ 147.00K	$ 81.00K
Gross Profit	-	$ 147.00K	$ 147.00K	$ 147.00K	-
EBIT	$ -119.12M	$ -103.16M	$ -97.57M	$ -84.89M	$ -80.99M
EBITDA	$ -129.57M	$ -112.05M	$ -104.55M	$ -89.26M	$ -80.70M
Net Income Common Stockholders	$ -119.12M	$ -103.16M	$ -97.57M	$ -76.19M	$ -76.96M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.34B	$ 1.44B	$ 1.47B	$ 1.12B	$ 1.19B
Total Assets	$ 1.39B	$ 1.47B	$ 1.51B	$ 1.16B	$ 1.23B
Total Debt	$ 15.61M	$ 15.81M	$ 4.76M	$ 5.33M	$ 5.89M
Net Debt	$ -1.33B	$ -1.42B	$ -1.47B	$ -1.12B	$ -1.19B
Total Liabilities	$ 62.78M	$ 48.90M	$ 26.42M	$ 1.16B	$ 44.46M
Stockholders Equity	$ 1.32B	$ 1.42B	$ 1.49B	$ 1.13B	$ 1.18B
Cash Flow	-
Free Cash Flow	$ -110.63M	$ -64.91M	$ -101.34M	$ -79.05M	$ -60.12M
Operating Cash Flow	$ -110.00M	$ -64.13M	$ -100.63M	$ -78.76M	$ -59.95M
Investing Cash Flow	$ 28.31M	$ -253.58M	$ -27.49M	$ -306.62M	$ -292.02M
Financing Cash Flow	$ 2.66M	$ 18.40M	$ 442.45M	$ 5.38M	$ 844.19M

Currency in USD

Karuna Therapeutics Earnings and Revenue History

Income Statement >

Karuna Therapeutics Debt to Assets

Balance Sheet >

Karuna Therapeutics Cash Flow

Cash Flow >

Karuna Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing